908 Devices Inc (MASS)

$6.22 +0.13 (2.13%)
Market Cap 226.90M
Revenue (ttm) 56.20M
Net Income (ttm) 19.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 34.68%
Debt to Equity Ratio 0.00
Volume 229,800
Avg Vol 324,098
Day's Range N/A - N/A
Shares Out 37.38M
Stochastic %K 9%
Beta 0.47
Analysts Strong Sell
Price Target $10.00

Company Profile

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extrace...

Industry: Medical Devices
Sector: Healthcare
Phone: 857-254-1500
Address:
44 3rd Avenue, Burlington, United States
Helloa11
Helloa11 Mar. 3 at 2:23 PM
$MASS How how can this go today ?
0 · Reply
JasonCO
JasonCO Mar. 3 at 12:29 PM
$MASS ARKK average is in the $40’s
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 3 at 12:22 PM
$MASS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.11 up 119.64% YoY • Reported revenue of $17.38M down -7.65% YoY • 908 Devices expects full year 2026 revenues to be in the range of $64.5M to $67.5M, representing 15% to 20% growth compared to 2025 revenue from continuing operations.
0 · Reply
ElizabethVoorhees140
ElizabethVoorhees140 Feb. 21 at 6:48 AM
$MASS Massimo Group operates specialty manufacturing. Revenue visibility is limited. Liquidity risk remains high.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 5:14 PM
$MASS RSI: 50.36, MACD: 0.1718 Vol: 0.34, MA20: 6.51, MA50: 6.05 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
lorenaw
lorenaw Feb. 8 at 11:24 PM
$MASS let’s go 🏈🏈🏈 !!! Good luck New England 🔥🔥🔥Patriots Superbowl LX 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼
1 · Reply
DARKP00L
DARKP00L Feb. 5 at 12:17 PM
$MASS 07:17 on Feb. 05 2026 908 Devices Updates MX908 Mission Mode For Hazardous Vapor Sampling And Adds Five New Drug Targets Including Medetomidine #tradeideas
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 10:59 PM
$MASS RSI: 69.89, MACD: 0.2438 Vol: 0.67, MA20: 5.85, MA50: 5.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 20 at 3:38 PM
ENERGY $MAAS $MASS $WATT initiating code energy for market
0 · Reply
Godwins26
Godwins26 Jan. 20 at 3:02 PM
Watchlist to the moon 🚀🌕 $IVF $RILY $KEP $IBRX $MASS
0 · Reply
Latest News on MASS
908 Devices to Present at the Sidoti Small Cap Conference

Mar 16, 2026, 7:00 AM EDT - 1 day ago

908 Devices to Present at the Sidoti Small Cap Conference

908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript

Mar 3, 2026, 5:02 PM EST - 14 days ago

908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

Mar 3, 2026, 7:00 AM EST - 14 days ago

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

908 Devices to Participate in Investor Conferences in March

Feb 24, 2026, 7:00 AM EST - 21 days ago

908 Devices to Participate in Investor Conferences in March

908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Feb 17, 2026, 7:00 AM EST - 4 weeks ago

908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

908 Devices Enhances MX908 Usability and Adds New Drug Targets

Feb 5, 2026, 7:00 AM EST - 5 weeks ago

908 Devices Enhances MX908 Usability and Adds New Drug Targets

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

Jan 20, 2026, 7:00 AM EST - 2 months ago

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 11:11 AM EST - 4 months ago

908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Nov 10, 2025, 7:00 AM EST - 4 months ago

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

908 Devices to Participate in Upcoming Investor Conferences

Oct 30, 2025, 7:00 AM EDT - 4 months ago

908 Devices to Participate in Upcoming Investor Conferences

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification

Oct 28, 2025, 7:00 AM EDT - 5 months ago

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 22, 2025, 7:00 AM EDT - 5 months ago

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices

Oct 16, 2025, 7:00 AM EDT - 5 months ago

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices

908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 2:24 PM EDT - 8 months ago

908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

Aug 5, 2025, 7:00 AM EDT - 8 months ago

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

Aug 4, 2025, 7:00 AM EDT - 8 months ago

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 7:00 AM EDT - 8 months ago

908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 22, 2025, 7:00 AM EDT - 8 months ago

908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025

908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

Jul 8, 2025, 7:00 AM EDT - 9 months ago

908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500

Jun 25, 2025, 8:03 AM EDT - 9 months ago

Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500

908 Devices Appoints Christopher D. Brown to its Board of Directors

Jun 16, 2025, 8:00 AM EDT - 9 months ago

908 Devices Appoints Christopher D. Brown to its Board of Directors

RGEN

Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit

Jun 3, 2025, 7:00 AM EDT - 10 months ago

Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit

908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference

May 22, 2025, 7:00 AM EDT - 10 months ago

908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference

908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript

May 13, 2025, 2:12 PM EDT - 11 months ago

908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript

908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

May 13, 2025, 7:00 AM EDT - 11 months ago

908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection

Apr 30, 2025, 7:00 AM EDT - 11 months ago

908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

Apr 22, 2025, 7:00 AM EDT - 11 months ago

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

Mar 11, 2025, 7:00 AM EDT - 1 year ago

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

908 Devices Makes Key Divestiture (Rating Upgrade)

Mar 6, 2025, 7:30 AM EST - 1 year ago

908 Devices Makes Key Divestiture (Rating Upgrade)

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

Mar 4, 2025, 1:26 PM EST - 1 year ago

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

RGEN

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 7:45 AM EST - 1 year ago

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

Mar 4, 2025, 7:30 AM EST - 1 year ago

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

RGEN

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Mar 3, 2025, 4:30 PM EST - 1 year ago

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 14, 2025, 4:01 PM EST - 1 year ago

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

Dec 19, 2024, 7:00 AM EST - 1 year ago

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:21 PM EST - 1 year ago

908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Nov 12, 2024, 7:00 AM EST - 1 year ago

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 22, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

Sep 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

Aug 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

Aug 6, 2024, 7:00 AM EDT - 1 year ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BCYC BSY MLI NJR OFIX QBTS SMMT

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

Jul 30, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 23, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

Jun 25, 2024, 7:00 AM EDT - 1 year ago

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Jun 18, 2024, 7:00 AM EDT - 1 year ago

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Lab Instrument Industry Update - New Commercial Entrants

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO CTKB DHR LAB OMIC QGEN

908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 1:21 PM EDT - 2 years ago

908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Apr 30, 2024, 7:45 AM EDT - 2 years ago

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

Apr 30, 2024, 7:30 AM EDT - 2 years ago

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

Apr 23, 2024, 7:00 AM EDT - 2 years ago

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

Helloa11
Helloa11 Mar. 3 at 2:23 PM
$MASS How how can this go today ?
0 · Reply
JasonCO
JasonCO Mar. 3 at 12:29 PM
$MASS ARKK average is in the $40’s
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 3 at 12:22 PM
$MASS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.11 up 119.64% YoY • Reported revenue of $17.38M down -7.65% YoY • 908 Devices expects full year 2026 revenues to be in the range of $64.5M to $67.5M, representing 15% to 20% growth compared to 2025 revenue from continuing operations.
0 · Reply
ElizabethVoorhees140
ElizabethVoorhees140 Feb. 21 at 6:48 AM
$MASS Massimo Group operates specialty manufacturing. Revenue visibility is limited. Liquidity risk remains high.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 5:14 PM
$MASS RSI: 50.36, MACD: 0.1718 Vol: 0.34, MA20: 6.51, MA50: 6.05 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
lorenaw
lorenaw Feb. 8 at 11:24 PM
$MASS let’s go 🏈🏈🏈 !!! Good luck New England 🔥🔥🔥Patriots Superbowl LX 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼
1 · Reply
DARKP00L
DARKP00L Feb. 5 at 12:17 PM
$MASS 07:17 on Feb. 05 2026 908 Devices Updates MX908 Mission Mode For Hazardous Vapor Sampling And Adds Five New Drug Targets Including Medetomidine #tradeideas
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 10:59 PM
$MASS RSI: 69.89, MACD: 0.2438 Vol: 0.67, MA20: 5.85, MA50: 5.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 20 at 3:38 PM
ENERGY $MAAS $MASS $WATT initiating code energy for market
0 · Reply
Godwins26
Godwins26 Jan. 20 at 3:02 PM
Watchlist to the moon 🚀🌕 $IVF $RILY $KEP $IBRX $MASS
0 · Reply
Godwins26
Godwins26 Jan. 20 at 3:01 PM
Watchlist $IVF $RILY $KEP $IBRX $MASS
0 · Reply
DARKP00L
DARKP00L Jan. 20 at 12:16 PM
$MASS 07:14 on Jan. 20 2026 908 Devices Reports Preliminary Q4 2025 Revenue Of $17.2M And Full-Year Revenue Of $56M, With Positive Adjusted EBITDA In Q4 #tradeideas
0 · Reply
DrStonkenstein
DrStonkenstein Jan. 8 at 9:36 AM
$CHOW Lazy, Incompetent, manipulative, and Dont speaaka tha Englgish .. what can anybody say about the chiity Wok.. $MASS $FUSE $HKIT
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 9:35 AM
$MASS RSI: 23.29, MACD: -0.3386 Vol: 0.52, MA20: 5.91, MA50: 6.52 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DoughCook
DoughCook Jan. 1 at 4:27 AM
$MASS — Momentum rolled over after a failed rally. Head & Shoulders breakdown puts sellers back in control.
0 · Reply
HamletHedge
HamletHedge Dec. 25 at 8:43 AM
$MASS Market tolerance narrows as uncertainty lingers, as investors weigh durability over pace. Measured progress can gradually rebuild conviction.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 18 at 4:14 PM
$MASS Share Price: $5.54 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $1.15 – $1.42 Target Zone: $2.00 – $2.45 Potential Upside: 65% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Helloa11
Helloa11 Nov. 11 at 9:57 PM
$MASS WTF again ? Down to below $6 from above $9 . Should have sold 50 % of it for profit.
2 · Reply
Zaksab
Zaksab Nov. 10 at 2:29 PM
$MASS uh oh
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 10 at 2:04 PM
$MASS (-15.3% pre) 908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook https://ooc.bz/l/83912
0 · Reply
DonCorleone77
DonCorleone77 Nov. 10 at 12:26 PM
$MASS 908 Devices reports Q3 EPS (41c), consensus (12c) -- Q3 revenue $14.01M, consensus $13.52M. -- Backs FY25 revenue view $54M-$56M, consensus $55.42M
0 · Reply
mrnobody617
mrnobody617 Nov. 7 at 3:58 PM
$TTD gets a $MASS FOR CHRIST SAKE! https://www.tipranks.com/news/blurbs/trade-desk-ttd-gets-a-buy-from-stifel-nicolaus-blurbs?mod=mw_quote_news
0 · Reply